View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
16 October 2018

Modality Solutions is Silver Sponsor and Exhibitor at BMWS

Modality Solutions has announced it will be a silver sponsor and exhibitor at Executive Platforms’ Biomanufacturing World Summit (BMWS).

Taking place from 29 October to 30 October in San Diego, California, the summit brings together pharmaceutical executives, cutting-edge technology providers and media partners for North America’s premier biologics event, including senior vice-presidents and vice-presidents of manufacturing, quality and supply chain, operations executives, directors of manufacturing, quality and supply chain, technology executives and plant / site managers.

Modality Solutions delivers integrated cold chain operations solutions for highly regulated life science and food industries. President Gary Hutchinson and principal Daniel Littlefield will attend the conference and participate in one-to-one meetings with other leaders in biopharmaceutical manufacturing and cold chain management.

BMWS’ attendees will have the opportunity to learn more about:

  • Industry challenges and opportunities
  • Quality as a culture, quality by design (QbD) and International Conference on Harmonisation (ICH) guidelines
  • Capacity management
  • Supply chain management
  • New processes and technologies
  • Working with an external partner

President Gary Hutchinson said: “As the global biopharmaceutical industry continues to grow and evolve, companies are constantly facing pressures to improve the quality, efficacy, cost and compliance for their life-saving products.

“We are committed to helping biopharmaceutical companies explore cost-reduction strategies, understand changing industry standards, and initiate risk management processes to ensure compliance, quality and product integrity.”

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics ( is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology